ACE2 and COVID-19: Furthermore, a cohort study demonstrated a significant enhancement of ACE2 expression in cholangiocytes (59.7% of cells) as compared with liver cells (2.6% of cells), indicating that COVID-19 can lead to direct damage of intrahepatic bile ducts.